Fierce Pharma Fierce Pharma

How Continuous Safety Monitoring Can Reduce Hospital Stays for High-Risk Oncology Patients

45 Minutes

Cellular therapy products such as CAR-T show promising clinical efficacy in fighting cancer. But the accompanying risk of fast-onset cytokine release syndrome (CRS) has driven a standard of care that includes lengthy hospital stays following infusion. Long hospital stays—often 2 weeks—present a high risk for infection along with a high financial and emotional burden for patients and families, and ultimately drive-up costs and reduce the accessibility of these therapies.

In this webinar, we'll discuss recent research at Mount Sinai evaluating the feasibility of dramatically reducing hospital stays for patients undergoing CAR-T therapy through the use of continuous safety monitoring in the Current Health platform.Study leaders will:

  • Discuss the context of CAR-T therapy and the business case for outpatient experiences.
  • Present and analyze the research study results.
  • Share insights into the patient experience.
  • Explore implications for the future of oncology care


current health

Sridevi Rajeeve, MD

Dr. Rajeeve is an Assistant attending physician with the Memorial Sloan-Kettering Cancer Center in New York specializing in Multiple Myeloma and Cellular Therapeutics. She completed her Internal Medicine residency training and Hematology-Oncology fellowship training at the Icahn School of Medicine at Mount Sinai in New York.Sridevi’s clinical and research interest span across plasma cell dyscrasias (Multiple Myeloma, Precursor states – monoclonal gammopathy of undetermined significance (MGUS)/smoldering multiple myeloma(SMM), Amyloidosis) and lymphoid malignancies, cellular therapeutics, clinical trials, digital health technologies and care delivery transformation.

current health

Nicole Zahradka, PhD

Dr Zahradka designs and implements studies to measure the clinical, financial and operational impact of care at home. She received her PhD in Biomechanics and Movement Science from the University of Delaware and has a background in Mechanical Engineering.Her previous research at Johns Hopkins University focused on wearables, data science, and clinical care. Dr Zahradka has expertise in leading clinical research studies that utilize digital technology to remotely monitor patients and deliver interventions across the care continuum.

Register here!

45 Minutes